Follow
Mayur K. Ladumor
Mayur K. Ladumor
Department of Pharmacokinetics, Dynamics, Metabolism & Bioanalytics (PDMB), Merck & Co. Inc.
Verified email at merck.com
Title
Cited by
Cited by
Year
Ontogeny of hepatic sulfotransferases and prediction of age-dependent fractional contribution of sulfation in acetaminophen metabolism
MK Ladumor, DK Bhatt, A Gaedigk, S Sharma, A Thakur, RE Pearce, ...
Drug Metabolism and Disposition 47 (8), 818-831, 2019
502019
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
MK Ladumor, A Thakur, S Sharma, A Rachapally, S Mishra, P Bobe, ...
Scientific reports 9 (1), 9709, 2019
452019
Study of degradation behaviour of montelukast sodium and its marketed formulation in oxidative and accelerated test conditions and prediction of physicochemical and ADMET …
SK Tiwari, DK Singh, MK Ladumor, AK Chakraborti, S Singh
Journal of Pharmaceutical and Biomedical Analysis 158, 106-118, 2018
232018
The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans
F Storelli, M Yin, AR Kumar, MK Ladumor, R Evers, PP Chothe, ...
Pharmacology & Therapeutics 238, 108271, 2022
212022
Contribution of uptake and efflux transporters to oral pharmacokinetics of furosemide
R Chapa, CY Li, A Basit, A Thakur, MK Ladumor, S Sharma, S Singh, ...
ACS omega 5 (51), 32939-32950, 2020
202020
Characterization of stress degradation products of amodiaquine dihydrochloride by liquid chromatography with high‐resolution mass spectrometry and prediction of their …
V Dhiman, DK Singh, MK Ladumor, S Singh
Journal of separation science 40 (23), 4530-4540, 2017
162017
Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry
A Sahu, M Narayanam, M Kurmi, MK Ladumor, S Singh
Magnetic Resonance in Chemistry 54 (8), 632-636, 2016
152016
Prediction of pregnancy-induced changes in secretory and total renal clearance of drugs transported by organic anion transporters
J Peng, MK Ladumor, JD Unadkat
Drug Metabolism and Disposition 49 (10), 929-937, 2021
132021
High-Resolution Mass Spectrometry in Metabolite Identification
MK Ladumor, S Tiwari, A Patil, K Bhavsar, S Jhajra, B Prasad, S Singh
Comprehensive Analytical Chemistry, 2016
132016
Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients
M Kurmi, A Sahu, MK Ladumor, AK Bansal, S Singh
Journal of Pharmaceutical and Biomedical Analysis 166, 174-182, 2019
102019
Characterization of stable and reactive metabolites of piperine formed on incubation with human liver microsomes
P Praneetha, A Balhara, MK Ladumor, DK Singh, A Patil, J Preethi, ...
Journal of mass spectrometry 54 (9), 738-749, 2019
82019
A physiologically-based pharmacokinetic model for cannabidiol in healthy adults, hepatically-impaired adults, and children
S Bansal, MK Ladumor, MF Paine, JD Unadkat
Drug Metabolism and Disposition 51 (6), 743-752, 2023
62023
Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio of P-glycoprotein and/or breast cancer resistance protein substrate drugs using a maternal-fetal …
J Peng, MK Ladumor, JD Unadkat
Drug Metabolism and Disposition 50 (5), 613-623, 2022
62022
Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes
MK Ladumor, F Storelli, X Liang, Y Lai, OJ Enogieru, PP Chothe, R Evers, ...
CPT: Pharmacometrics & Systems Pharmacology 12 (2), 261-273, 2023
52023
In vitro evaluation of reactive nature of E-and Z-guggulsterones and their metabolites in human liver microsomes using UHPLC-Orbitrap mass spectrometer
A Balhara, M Ladumor, DK Singh, P Praneetha, J Preethi, S Pokharkar, ...
Journal of Pharmaceutical and Biomedical Analysis 186, 113275, 2020
52020
Predicting regional respiratory tissue and systemic concentrations of orally inhaled drugs through a novel PBPK model
MK Ladumor, JD Unadkat
Drug Metabolism and Disposition 50 (5), 519-528, 2022
42022
Exploration of the plausible mechanism of ethambutol induced ocular toxicity by using proteomics informed physiologically based pharmacokinetic (PBPK) modeling
A Balhara, MK Ladumor, RP Nankar, SD Syed, S Giri, B Prasad, S Singh
Pharmaceutical Research 39 (4), 677-689, 2022
12022
Identification of novel glutathione conjugates of terbinafine in liver microsomes and hepatocytes across species
A Patil, MK Ladumor, SH Kamble, BM Johnson, M Subramanian, MW Sinz, ...
Xenobiotica, 2019
12019
The JPET Editorial Fellowship: Opening the Blinds to the Peer Review and Editorial Process
MK Ladumor, CA Mielnik, CD Peterson, F Rwere, ER Gross
The Journal of pharmacology and experimental therapeutics 389 (2), 129-132, 2024
2024
Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model
F Storelli, MK Ladumor, X Liang, Y Lai, PP Chothe, OJ Enogieru, R Evers, ...
CPT: Pharmacometrics & Systems Pharmacology 13 (1), 118-131, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20